RT Journal Article
SR Electronic
T1 Divide in Vaccine Belief in COVID-19 Conversations: Implications for Immunization Plans
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.23.20160887
DO 10.1101/2020.07.23.20160887
A1 Tyagi, Aman
A1 Carley, Kathleen M.
YR 2020
UL http://medrxiv.org/content/early/2020/07/29/2020.07.23.20160887.abstract
AB The development of a viable COVID-19 vaccine is a work in progress, but the success of the immunization campaign will depend upon public acceptance. In this paper, we classify Twitter users in COVID-19 discussion into vaccine refusers (anti-vaxxers) and vaccine adherers (vaxxers) communities. We study the divide between anti-vaxxers and vaxxers in the context of whom they follow. More specifically, we look at followership of 1) the U.S. Congress members, 2) four major religions (Christianity, Hinduism, Judaism and Islam), 3) accounts related to the healthcare community, and 4) news media accounts. Our results indicate that there is a partisan divide between vaxxers and anti-vaxxers. We find a religious community with a higher than expected fraction of anti-vaxxers. Further, we find that the variance of vaccine belief within the news media accounts operated by Russian and Iranian governments is higher compared to news media accounts operated by other governments. Finally, we provide messaging and policy implications to inform the COVID-19 vaccine and future vaccination plans.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors would like to acknowledge the support of Department of Engineering and Public Policy, Carnegie Mellon University and center for Computational Analysis of Social and Organizational Systems (CASOS), Carnegie Mellon University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe will provide the list of accounts from each group used in our analysis on https://kilthub.cmu.edu/ as part of reviewed publication.